George Sakoulas, MD
Enriched profileAdjunct Professor, Pediatrics (Division of Host-Microbe Systems and Therapeutics), University of California, San Diego School of Medicine · University of California, San Diego
George Sakoulas is Adjunct Professor, Pediatrics (Division of Host-Microbe Systems and Therapeutics), University of California, San Diego School of Medicine at University of California, San Diego. OpenAlex indexes 413 publications with 16,495 citations (h-index 66); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
George Sakoulas, MD, is Adjunct Professor, Pediatrics (Division of Host-Microbe Systems and Therapeutics), University of California, San Diego School of Medicine. The public record shows 413 publications with 16,495 citations (h-index 66), centered on COVID-19. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 18 companies, 1 NIH-funded awards (2011–2015).
- Most recent indexed publication: 2026 · Open forum infectious diseases
- Top research focus: COVID-19
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 18 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 15 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation
Sponsor: Sharp HealthCare
- Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19
Sponsor: George Sakoulas, MD
Industry payments
Updated 27 Aug 2026
18 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Paratek Pharmaceuticals, Inc.Program year202556 payments$42,412openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202548 payments$40,967openpaymentsdata.cms.gov ↗
- La Jolla Pharmaceutical CompanyProgram year202512 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Tetracycline-class Drug23%Minocycline Hcl56%Doxycycline Hyclate28%Doxycycline Monohydrate16%Part D<11 patientsMacrolide Antimicrobial16.1%Azithromycin100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2011–2015 per NIH RePORTER. The latest:
- Drug-Drug Interactions between Pharmaceutical and Endogenous Antibiotics
University of California, San Diego
FY2015$129,287U54HD071600 - Drug-Drug Interactions between Pharmaceutical and Endogenous Antibiotics
University of California, San Diego
FY2014$128,126U54HD071600 - Drug-Drug Interactions between Pharmaceutical and Endogenous Antibiotics
University of California, San Diego
FY2013$125,193U54HD071600
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Overcoming Ceftaroline Resistance in MRSA Using Ceftaroline-Carbapenem Combination Therapy.
Open forum infectious diseases
Article2026 - Risk Factors for Hospital Readmission Following Outpatient Parenteral Antimicrobial Therapy (OPAT).
Infectious diseases and therapy
Article2025 - Enhanced Killing of Methicillin-Resistant Staphylococcus aureus With Ceftaroline or Vancomycin in Combination With Carbapenems.
The Journal of infectious diseases
Article2025 - Rapid valve sterilization with meropenem plus ceftolozane/tazobactam combination therapy for Pseudomonas aeruginosa prosthetic valve endocarditis.
JAC-antimicrobial resistance
Article2025 - Ethylenediaminetetraacetic Acid Enhances Vancomycin and Reactive Oxygen Species-Mediated Killing of Vancomycin-Intermediate Staphylococcus aureus.
Open forum infectious diseases
Article2025
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/scientific-contributions/George-Sakoulas-38367535
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/george-sakoulas-b46907365
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clinician.nejm.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clinician.nejm.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clinician.nejm.org ↗
- Board Certified
Infectious Disease, American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- Associate Editor
New England Journal of Medicine (NEJM)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clinician.nejm.org ↗ - Chair of Infectious Disease
Sharp Rees-Stealy Medical Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clinician.nejm.org ↗ - Director of Transplant Infectious Disease
Sharp Healthcare
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clinician.nejm.org ↗
Secondary affiliations
appointments beyond the home institution- Infectious Diseases Clinician
Sharp Memorial Hospital and Sharp Rees-Stealy Medical Group, San Diego, CA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sharp.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ravindra Mehta, MD
University of California, San Diego
Barry Greenberg, MD
University of California, San Diego
Anthony Demaria, MD
University of California, San Diego
Arthur Kavanaugh, MD
University of California, San Diego